intellimed appointed as the official distributor of Riverain Technologies in Switzerland 🇨🇭
intellimed, a Swiss provider of innovative radiology and AI solutions, is now the official distributor of Riverain Technologies in Switzerland. Riverain is internationally recognized for its ClearRead™ CT platform, which enhances chest imaging interpretation using advanced Clear Visual Intelligence™ technology.
ClearRead CT improves visibility of pulmonary structures by suppressing bones, vessels, and imaging noise, supporting more accurate and efficient detection of lung nodules. The software is compatible with all CT scanners, supports contrast and non-contrast studies, and integrates directly into existing PACS environments without additional viewer applications.
ClearRead™ CT Capabilities
Vessel Suppress: Enhances visibility of lung tissue by removing overlying structures.
Detect: AI-powered identification of all nodule types for faster, more confident diagnosis.
Compare : Automatically tracks nodule changes over time for follow-up efficiency.
CAC Analysis: Delivers coronary artery calcification data from routine CTs.
ClearRead CT is FDA-cleared and CE-marked (MDR Class IIa). Clinical studies demonstrate improved diagnostic accuracy and reduced interpretation time when used concurrently with standard CT review.
Purpose for the Swiss Market
The introduction of ClearRead CT in Switzerland supports ongoing efforts to improve early lung cancer detection, optimize CT imaging workflows, and provide actionable cardiovascular risk information from existing thoracic CT studies. With local distribution and support provided by intellimed, Swiss healthcare institutions can evaluate and adopt the solution with integrated training, service and implementation support.
About Riverain Technologies
Riverain Technologies is a global medical-technology company committed to revolutionizing thoracic imaging interpretation through AI-powered Clear Visual Intelligence™ solutions. By deploying FDA-cleared, clinically proven deep-learning software that integrates seamlessly into existing PACS workflows, Riverain enables radiologists to "see clearly and decide confidently." The company's offerings - including advanced tools for lung nodule detection, vessel suppression, and coronary-artery-calcification analysis - are designed to improve diagnostic accuracy, accelerate reading times, and support lung-screening and cardio-thoracic programs worldwide. With a strong network of healthcare partners and a focus on eliminating delayed cardio-thoracic disease diagnoses, Riverain Technologies empowers hospitals and imaging centers to adopt cutting-edge AI innovations while maintaining streamlined clinical operations.
https://www.riveraintech.com/